Caren van Roekel

133 One-day treatment in 166 Ho-radioembolization 10. Van den Bosch MA. Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization (SIM). clinicaltrials.gov; 2014 [cited 2019 December 24]; Available from: https://clinicaltrials.gov/c t2/show/ NCT02208804?term=NCT02208804& draw=2&rank=1. 11. Kafrouni M, Allimant C, Fourcade M, Vauclin S, Delicque J, Ilonca AD, et al. Retrospective Voxel-Based Dosimetry for Assessing the Ability of the Body- Surface-Area Model to Predict Delivered Dose and Radioembolization Outcome. J Nucl Med. 2018;59(8):1289-95. Epub 2018/03/17. 12. Gates V, Salem R. Reply to “hepatic radioembolization as a true single- session treatment”. J Vasc Interv Radiol. 2014;25(7):1144-6. Epub 2014/06/28. 13. SalemR, Thurston KG. Radioembolization with 90Yttrium microspheres: a state- of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. J Vasc Interv Radiol. 2006;17(8):1251-78. Epub 2006/08/23. 14. Chiesa C, Sjogreen Gleisner K, Flux G, Gear J, Walrand S, Bacher K, et al. The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy. Eur J Nucl Med Mol Im. 2017;44(11):1783-6. Epub 2017/05/26. 15. Tong AK, Kao YH, Too CW, Chin KF, Ng DC, Chow PK. Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry. Br J Radiol. 2016;89(1062):20150943. Epub 2016/03/05. 16. Braat AJAT, Kappadath SC, Bruijnen RCG, van den Hoven AF, Mahvash A, de Jong HWAM, et al. Adequate SIRT activity dose is as important as adequate chemotherapy dose. Lancet Oncol. 2017;18(11):e636. 17. Bastiaannet R, Kappadath SC, Kunnen B, Braat A, Lam M, de Jong H. The physics of radioembolization. EJNMMI Physics. 2018;5(1):22. Epub 2018/11/06. 18. Tosk ich BB , L iu DM. Y90 Radioembolization Dosimetry: Concepts for the Interventional Radiologist. Tech Vasc Interv Radiol. 2019;22(2):100-11. Epub 2019/05/14. 19. Garin E, Rolland Y, Pracht M, Le Sourd S, Laffont S, Mesbah H, et al. High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with (90) Y-loaded glass microsphere radioembolization. Liver International. 2017;37(1):101-10. Epub 2016/08/16. 4